| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Molecular Endocrinology, Vol 7, 441-452, Copyright © 1993 by Endocrine Society
ARTICLES |
H Cho and BS Katzenellenbogen
Department of Physiology and Biophysics, University of Illinois, Urbana 61801.
Since we have observed effects of growth factors and cAMP as well as estradiol (E2) on regulation of expression of some genes stimulated by the estrogen receptor (ER), we have undertaken studies to examine directly whether activators of protein kinases can modulate transcriptional activity of the ER. We find that activators of protein kinase-A [cholera toxin plus 3-isobutyl-1-methylxanthine (CT+IBMX)] and protein kinase-C [12-O-tetradecanoylphorbol-13-acetate (TPA)] markedly synergize with E2 in ER-mediated transcriptional activation. When a reporter plasmid [with a minimal promoter containing a TATA region and estrogen-responsive elements (ERE) linked to a chloramphenicol acetyltransferase (CAT) reporter gene] was transfected into MCF-7 human breast cancer cells, which contain endogenous ER, E2 evoked a dose- dependent increase in CAT activity. While treatment with protein kinase- A or -C activator alone evoked only very low CAT activity, the maximal (approximately 25-fold) CAT activity stimulated by E2 alone was increased 2- to 3-fold (to approximately 60 times the control value) upon cotreatment with either of the protein kinase activators. Interestingly, antiestrogen abolished all of the CAT activity induced by E2 and protein kinase activators. Immunoblots showed that TPA reduced ER levels to 30% of control values after 24 h, while CT+IBMX increased levels about 1.5-fold. Scatchard binding analysis revealed no change in the binding affinity of E2 to ER by these agents. Gel mobility shift competition assays with extracts prepared from cells that had been treated with E2 and protein kinase activators did not reveal any quantitative or qualitative changes in the binding of ER to the ERE in vitro. In ER-deficient Chinese hamster ovary (CHO) cells transfected with the reporter gene and varying amounts of an ER expression vector, the level of CAT activity obtained by cotreatment with E2 and CT+IMBX was 3-fold higher than that observed with E2 alone over the range of different ER amounts tested. This ER-mediated synergism was still retained in an amino-terminal A/B-domain-deleted ER mutant lacking the hormone-independent transcriptional activation function (TAF-1), but was greatly reduced in two hormone-binding domain (region E) mutants that exhibit significantly diminished ligand- dependent transcriptional activation. TPA did not show any synergistic activation with E2 in CHO cells, indicating differences in responses between cell types.(ABSTRACT TRUNCATED AT 400 WORDS)
This article has been cited by other articles:
 |
|
 |
|
  E. N. Nierth-Simpson, M. M. Martin, T.-C. Chiang, L. I. Melnik, L. V. Rhodes, S. E. Muir, M. E. Burow, and J. A. McLachlan Human Uterine Smooth Muscle and Leiomyoma Cells Differ in Their Rapid 17{beta}-Estradiol Signaling: Implications for Proliferation Endocrinology, May 1, 2009; 150(5): 2436 - 2445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. S. Fenne, T. Hoang, M. Hauglid, J. V. Sagen, E. A. Lien, and G. Mellgren Recruitment of Coactivator Glucocorticoid Receptor Interacting Protein 1 to an Estrogen Receptor Transcription Complex Is Regulated by the 3',5'-Cyclic Adenosine 5'-Monophosphate-Dependent Protein Kinase Endocrinology, September 1, 2008; 149(9): 4336 - 4345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Olesen, H. M. Jessen, C. J. Auger, and A. P. Auger Dopaminergic Activation of Estrogen Receptors in Neonatal Brain Alters Progestin Receptor Expression and Juvenile Social Play Behavior Endocrinology, September 1, 2005; 146(9): 3705 - 3712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Adamski and E. N. Benveniste 17{beta}-Estradiol Activation of the c-Jun N-Terminal Kinase Pathway Leads to Down-Regulation of Class II Major Histocompatibility Complex Expression Mol. Endocrinol., January 1, 2005; 19(1): 113 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Cui, M. Zhang, R. Pestell, E. M. Curran, W. V. Welshons, and S. A. W. Fuqua Phosphorylation of Estrogen Receptor {alpha} Blocks Its Acetylation and Regulates Estrogen Sensitivity Cancer Res., December 15, 2004; 64(24): 9199 - 9208. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Adamski, Z. Ma, S. Nozell, and E. N. Benveniste 17{beta}-Estradiol Inhibits Class II Major Histocompatibility Complex (MHC) Expression: Influence on Histone Modifications and CBP Recruitment to the Class II MHC Promoter Mol. Endocrinol., August 1, 2004; 18(8): 1963 - 1974. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-W. Tsai, J. A. Katzenellenbogen, B. S. Katzenellenbogen, and M. A. Shupnik Protein Kinase A Activation of Estrogen Receptor {alpha} Transcription Does Not Require Proteasome Activity and Protects the Receptor from Ligand-Mediated Degradation Endocrinology, June 1, 2004; 145(6): 2730 - 2738. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Barletta, P. Dhawan, and S. Christakos Integration of hormone signaling in the regulation of human 25(OH)D3 24-hydroxylase transcription Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E598 - E608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Blaustein Minireview: Neuronal Steroid Hormone Receptors: They're Not Just for Hormones Anymore Endocrinology, March 1, 2004; 145(3): 1075 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Gomez and J. A. Balsa Autocrine/Paracrine Action of Pituitary Vasoactive Intestinal Peptide on Lactotroph Hyperplasia Induced by Estrogen Endocrinology, October 1, 2003; 144(10): 4403 - 4409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. W. Braun, M.-N. Vo, and K. H. Kim Positive Regulation of Retinoic Acid Receptor Alpha by Protein Kinase C and Mitogen-Activated Protein Kinase in Sertoli Cells Biol Reprod, July 1, 2002; 67(1): 29 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Jones, R. J. Schmidt, R. T. Pickard, P. S. Foxworthy, and P. I. Eacho Estrogen receptor-mediated repression of human hepatic lipase gene transcription J. Lipid Res., March 1, 2002; 43(3): 383 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Oh, L. A. Lorant, J. N. Holloway, D. L. Miller, F. G. Kern, and D. El-Ashry Hyperactivation of MAPK Induces Loss of ER{alpha} Expression in Breast Cancer Cells Mol. Endocrinol., August 1, 2001; 15(8): 1344 - 1359. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Sewack, T. W. Ellis, and U. Hansen Binding of TATA Binding Protein to a Naturally Positioned Nucleosome Is Facilitated by Histone Acetylation Mol. Cell. Biol., February 15, 2001; 21(4): 1404 - 1415. [Abstract] [Full Text]
|
|
|
|
|
|
G. Lazennec, L. Canaple, D. Saugy, and W. Wahli Activation of Peroxisome Proliferator-Activated Receptors (PPARs) by Their Ligands and Protein Kinase A Activators Mol. Endocrinol., December 1, 2000; 14(12): 1962 - 1975. [Abstract] [Full Text]
|
|
|
|
|
|
D. Chen, P. E. Pace, R. C. Coombes, and S. Ali Phosphorylation of Human Estrogen Receptor alpha by Protein Kinase A Regulates Dimerization Mol. Cell. Biol., February 1, 1999; 19(2): 1002 - 1015. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Massaad, N. Houard, M. Lombès, and R. Barouki Modulation of Human Mineralocorticoid Receptor Function by Protein Kinase A Mol. Endocrinol., January 1, 1999; 13(1): 57 - 65. [Abstract] [Full Text]
|
|
|
|
|
|
S. Migliaccio, T. F. Washburn, S. Fillo, H. Rivera, A. Teti, K. S. Korach, and W. C. Wetsel Modulation of Estrogen Receptor Levels in Mouse Uterus by Protein Kinase C Isoenzymes Endocrinology, November 1, 1998; 139(11): 4598 - 4606. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Moilanen, U. Karvonen, H. Poukka, O. A. Jänne, and J. J. Palvimo Activation of Androgen Receptor Function by a Novel Nuclear Protein Kinase Mol. Biol. Cell, September 1, 1998; 9(9): 2527 - 2543. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. Ansonoff and A. M. Etgen Estradiol Elevates Protein Kinase C Catalytic Activity in the Preoptic Area of Female Rats Endocrinology, July 1, 1998; 139(7): 3050 - 3056. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. I. Macgregor and V. C. Jordan Basic Guide to the Mechanisms of Antiestrogen Action Pharmacol. Rev., June 1, 1998; 50(2): 151 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. B. Joel, A. M. Traish, and D. A. Lannigan Estradiol-induced Phosphorylation of Serine 118 in the Estrogen Receptor Is Independent of p42/p44 Mitogen-activated Protein Kinase J. Biol. Chem., May 22, 1998; 273(21): 13317 - 13323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kahmann, L. Vaßen, and L. Klein-Hitpass Synergistic Enhancement of PRB-Mediated RU486 and R5020 Agonist Activities through Cyclic Adenosine 3',5'-Monophosphate Represents a Delayed Primary Response Mol. Endocrinol., February 1, 1998; 12(2): 278 - 289. [Abstract] [Full Text]
|
|
|
|
|
|
S. Leers-Sucheta, K.-i. Morohashi, J. I. Mason, and M. H. Melner Synergistic Activation of the Human Type II 3beta -Hydroxysteroid Dehydrogenase/Delta 5-Delta 4 Isomerase Promoter by the Transcription Factor Steroidogenic Factor-1/Adrenal 4-binding Protein and Phorbol Ester J. Biol. Chem., March 21, 1997; 272(12): 7960 - 7967. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. C. Leitman, C. H.R.M. Costa, H. Graf, J. D. Baxter, and R. C.J. Ribeiro Thyroid Hormone Activation of Transcription Is Potentiated by Activators of cAMP-dependent Protein Kinase J. Biol. Chem., September 6, 1996; 271(36): 21950 - 21955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Venkov, A. B. Rankin, and D. E. Vaughan Identification of Authentic Estrogen Receptor in Cultured Endothelial Cells: A Potential Mechanism for Steroid Hormone Regulation of Endothelial Function Circulation, August 15, 1996; 94(4): 727 - 733. [Abstract] [Full Text]
|
|
|
|
 |
|
 G. Gu, A. A. Rojo, M. C. Zee, J. Yu, and R. B. Simerly Hormonal Regulation of CREB Phosphorylation in the Anteroventral Periventricular Nucleus J. Neurosci., May 1, 1996; 16(9): 3035 - 3044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Martin, P. Garcia-Morales, A. Stoica, H. B. Solomon, M. Pierce, D. Katz, S. Zhang, M. Danielsen, and M. Saceda Effects of 12-O-Tetradecanoylphorbol-13-acetate on Estrogen Receptor Activity in MCF-7 Cells J. Biol. Chem., October 20, 1995; 270(42): 25244 - 25251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Oshima, D. Szapary, and S. S. Simons Jr. The Factor Binding to the Glucocorticoid Modulatory Element of the Tyrosine Aminotransferase Gene Is a Novel and Ubiquitous Heteromeric Complex J. Biol. Chem., September 15, 1995; 270(37): 21893 - 21901. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. K. Leslie, D. Keefe, S. Powell, and F. Naftolin Estrogen Receptors Are Identified in the Glioblastoma Cell Line UI38MG Reproductive Sciences, July 1, 1994; 1(3): 238 - 244. [Abstract] [PDF]
|
|
|
|
|
|
R. Duan, W. Xie, R. C. Burghardt, and S. Safe Estrogen Receptor-mediated Activation of the Serum Response Element in MCF-7 Cells through MAPK-dependent Phosphorylation of Elk-1 J. Biol. Chem., April 6, 2001; 276(15): 11590 - 11598. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
